EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -2.731
March 31, 2026 -3.163
December 31, 2025 -3.173
September 30, 2025 -3.627
June 30, 2025 -3.524
March 31, 2025 -3.136
December 31, 2024 -2.878
September 30, 2024 -3.302
June 30, 2024 -3.811
March 31, 2024 -4.460
December 31, 2023 -5.150
September 30, 2023 -5.000
June 30, 2023 -4.693
March 31, 2023 -4.174
December 31, 2022 -3.786
September 30, 2022 -3.380
June 30, 2022 -3.017
March 31, 2022 -2.863
Date Value
December 31, 2021 -2.672
September 30, 2021 -2.897
June 30, 2021 -2.844
March 31, 2021 -2.773
December 31, 2020 -2.668
September 30, 2020 -2.082
June 30, 2020 -2.077
March 31, 2020 -2.798
December 31, 2019 -2.663
September 30, 2019 -2.860
June 30, 2019 -2.764
March 31, 2019 -1.649
December 31, 2018 -1.299
September 30, 2018 -1.214
June 30, 2018 -0.7838
March 31, 2018 -0.5059
December 31, 2017 -0.3618

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Autolus Therapeutics Plc -1.050
Akari Therapeutics Plc -19.78
Cellectis SA -0.6502
DBV Technologies SA -3.514
Biodexa Pharmaceuticals Plc -6.696